馃摚#NewPublication: Results from the #MASTERPLAN randomised phase 2 trial have been presented at #ESMO26 and published in @TheLancetOncol.
馃挕The trial investigated whether adding stereotactic body radiotherapy, or SBRT, to chemotherapy could improve local control for people with high-risk, localised pancreatic cancer.
馃搳At 12 months, locoregional recurrence occurred in 20% of participants who received SBRT and chemotherapy, compared with 52% who received chemotherapy alone, without a clear increase in clinically important toxicity. A larger study is needed to confirm the findings.
馃敆Read the paper: https://doi.org/10.1016/S1470-2045(26)00532-2
馃檹Congratulations to the MASTERPLAN study team, including @trialscentre, @GICancerTrials, @TROGfightcancer, the participating sites, and especially the patients and families involved.
#PancreaticCancer #CancerResearch #ClinicalTrials #SBRT | @Sydney_Uni
50 views 路 0 likes 路 0 reposts 路 0 replies
Randomised phase II study of mFOLFIRINOX 卤 SBRT in patients with high risk, borderline resectable or locally advanced pancreatic cancer: Results of the AGITG MASTERPLAN trial
https://esmocongress.esmo.orgSource: Sydney Clinical Trials Centre 路 x.com